Speaking in favour of administering an additional dose of the COVID-19 vaccine, Dr Gagandeep Kang said: “South African data shows COVID-19 positive children are hospitalised for other reasons. Need to worry about Sars-Cov2 virus in immuno-compromised children…

The SEC met on December 10 to review the applications made by both Serum Institute, which manufactures Oxford-AstraZeneca’s COVID-19 vaccine Covishield in India, and Biological E which makes Corbevax coronavirus vaccine.

Similar restrictions have been implemented in Maharashtra and Karnataka also, where only vaccinated people would be allowed in public places.

Arvind Kejriwal thanked healthcare workers and doctors for helping Delhi achieve this feat and wrote on Twitter: “Salute to Doctors, ANMs, Teachers, ASHAs, CDVs, and all other frontline workers. Congratulations to DMs, CDMOs, DIOs, and all district functionaries.”

Narendra Modi declares in his national address that India will start administering booster shots of Coronavirus vaccine from January 10

ZyCov-D is a needle-free three-dose vaccine. The three doses of the jab are to be administered 28 days apart

In a significant move, Prime Minister Narendra Modi said on December 25 that India would start giving a third 'precautionary dose' to healthcare and frontline workers and those above 60 with comorbidities from January 10. Children aged 15-18 will also be…

"Covid vaccination of children in the age group of 15-18 years to be started from 3rd January 2022. For such beneficiaries, vaccination option would be Covaxin only," the guidelines stated.

No one can quite say how India’s indigenous Covid-19 vaccine company will meet the challenge of vaccinating close to 10 crore Indians between the ages of 15-18 next month

Corbevax, the COVID-19 vaccine produced by Hyderabad-based vaccine major Biological-E in collaboration with US-based Dynavax and Baylor College of Medicine, is also India’s first indigenously developed protein sub-unit vaccine against the virus.